IRIS
COLUCCI, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.152
EU - Europa 1.983
AS - Asia 886
SA - Sud America 5
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.033
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.144
CN - Cina 571
SE - Svezia 445
DE - Germania 408
SG - Singapore 265
IT - Italia 263
UA - Ucraina 250
FI - Finlandia 172
RU - Federazione Russa 156
FR - Francia 102
GB - Regno Unito 93
IE - Irlanda 40
BE - Belgio 22
IN - India 22
CA - Canada 8
NL - Olanda 7
CZ - Repubblica Ceca 6
HK - Hong Kong 6
IR - Iran 4
KR - Corea 4
LT - Lituania 4
VN - Vietnam 4
AU - Australia 3
EU - Europa 3
AR - Argentina 2
AT - Austria 2
BR - Brasile 2
IL - Israele 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IS - Islanda 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 11.033
Salva come PNG Salva come JPEG
Città #
Fairfield 1.157
Woodbridge 1.029
Houston 689
Chandler 667
Jacksonville 606
Ashburn 550
Seattle 501
Cambridge 414
Ann Arbor 397
Wilmington 388
Nyköping 380
Singapore 210
Roxbury 162
Lawrence 159
Nanjing 158
Des Moines 96
Beijing 91
Boardman 88
Bari 87
New York 65
Princeton 61
San Diego 61
Inglewood 53
Strasbourg 49
Hebei 42
Brooklyn 41
Nanchang 41
Shenyang 40
Dublin 39
Grafing 37
Santa Clara 26
Tianjin 25
Brussels 22
Jiaxing 21
Dearborn 20
Changsha 19
London 19
Los Angeles 16
Paris 16
Pune 15
Helsinki 14
Rome 12
Guangzhou 11
Auburn Hills 10
Frankfurt am Main 10
Redwood City 10
Kunming 9
Munich 9
San Mateo 9
Jinan 8
Augusta 7
Zhengzhou 7
Espoo 6
Foggia 6
Genoa 6
Milan 6
Brno 5
Mola Di Bari 5
Norwalk 5
Shanghai 5
Toronto 5
Dong Ket 4
Hong Kong 4
Napoli 4
Ningbo 4
Quanzhou 4
San Francisco 4
Wuhan 4
Ardabil 3
Bethlehem 3
Bologna 3
Cagliari 3
Chicago 3
Detroit 3
Heze 3
Hounslow 3
Indiana 3
Leawood 3
Lecce 3
Monmouth Junction 3
San Pietro in Cariano 3
Capraia e Limite 2
Chengdu 2
Chongqing 2
Cutrofiano 2
Florence 2
Guagnano 2
Hangzhou 2
Kilburn 2
La Plata 2
Melbourne 2
Monopoli 2
Mumbai 2
Noci 2
Ottawa 2
Palermo 2
Rogeno 2
Romola 2
Salerno 2
Salsomaggiore Terme 2
Totale 8.827
Salva come PNG Salva come JPEG
Nome #
Platelet drop and fibrinolytic shutdown in patients with sepsis 128
Histones differentially modulate the anticoagulant and profibrinolytic activities of heparin, heparin derivatives and dabigatran. 125
Factor IX-Padua enhances the fibrinolytic resistance of plasma clots 121
Fisiologia dell'Emostasi 119
Coagulation activation is associated with nicotinamide adenine dinucleotide phosphate oxidase-dependent reactive oxygen species generation in hemodialysis patients. 117
Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation 114
Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors 110
Cultured human endothelial cells generate tissue factor in response to endotoxin 109
Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism 109
Coagulopathy of Acute Sepsis 109
A modified prothrombin time to measure the anticoagulant activity of dabigatran 109
Influence of cell-associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding 109
Tissue factor in health and disease 107
Co-administration of low molecular weight heparin enhances the profibrinolytic effect of warfarin through different mechanisms. 107
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression 106
Grape intake reduces thrombin generation and enhances plasma fibrinolysis. Potential role of circulating procoagulant microparticles 105
Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway 102
In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis. Study in healthy subjects and correlation with blood fibrinolytic parameters 101
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein C reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation 100
Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis 100
Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots 100
Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation 98
Role of leucocyte procoagulant activity in endotoxin-induced DIC: evidence from comparative studies in rats and rabbits. 98
Effect of ochratoxin A on prothrombotic and proinflammatory activities of stimulated blood mononuclear cells 98
Sepsis, thrombosis and organ dysfunction 96
Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection 96
Platelets and fibrinolysis 96
Antithrombotic activity of 12 table grape varieties. Relationship with polyphenolic profile 93
CHANGES IN THE COAGULATION-FIBRINOLYSIS BALANCE OF ENDOTHELIAL-CELLS AND MONONUCLEAR PHAGOCYTES - ROLE IN DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH INFECTIOUS-DISEASES 93
TAFI deficiency in liver cirrhosis: relation with plasma fibrinolysis and survival 92
Reduced generation of procoagulant activity by endotoxin-stimulated mononuclear cells from patients with chronic myeloid leukaemia. 92
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 91
Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein. 91
FAILURE OF WARFARIN TO AFFECT THE TISSUE FACTOR ACTIVITY AND THE METASTATIC POTENTIAL OF MURINE FIBRO-SARCOMA CELLS. 89
Blood and tissue fibrinolytic profile in patients with colorectal cancer 88
Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor 88
Complement-dependent and complement-independent interactions of bacterial lipopolysaccharides and mucopeptides with rabbit and human platelets. 87
Hyperprothrombinemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis 87
FVIII/VWF complex displays a greater pro-hemostatic activity than FVIII preparations devoid of VWF. Study in plasma and cell-based models 87
In vitro inhibition of monocyte tissue factor and PAI-2 production by Ochratoxin A 86
Thrombolysis enhancing activity of a low molecular weight dermatan sulfate (Desmin 370) in experimental pulmonary embolism in rats. 86
Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies 86
Monocytes, but not endothelial cells, downregulate the anticoagulant activity of activated protein C 85
ENHANCED ENDOTHELIAL TISSUE FACTOR BUT NORMAL THROMBOMODULIN IN ENDOTOXIN-TREATED RABBITS. 85
Procoagulant activity of sarcoma sublines with different metastatic potential 84
Stroke in two young siblings with congenital dysfibrinogenemia. 84
Cancer cell procoagulant: a novel vitamin K-dependent activity. 84
Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice 83
A hitherto undescribed defect of platelet coagulant activity in polycythaemia vera and essential thrombocythaemia. 82
Cancer cell procoagulant activity: evaluation by an amidolytic assay. 82
Low D-dimer levels in sepsis: Good or bad? 82
Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential 81
null 80
Unbalanced coagulation-fibrinolysis potential during L-Asparaginase therapy in children with acute lymphoblastic leukaemia 80
Gene expression signature induced by grape intake in healthy subjects reveals wide-spread beneficial effects on peripheral blood mononuclear cells 80
Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells 79
Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency. 78
Increased mononuclear cell tissue factor and type-2 plasminogen activator inhibitor and reduced plasma fibrinolytic capacity in children with lymphoma 78
Reduction of the plasma levels of tissue plasminogen activator after infusion of a lipid emulsion in humans 78
Ochratoxin A inhibits the production of tissue factor and plasminogen activator inhibitor-2 by human blood mononuclear cells: Another potential mechanism of immune-suppression 78
Early increase of a new platelet coagulant activity in rats fed a thrombogenic diet. 77
Increased macrophage procoagulant activity but normal endothelial thrombomodulin in rabbits fed an atherogenic diet 76
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors 76
EXPERIMENTAL ENDOTOXEMIA AS A MODEL OF IMPAIRED FIBRINOLYSIS 75
REDUCED FIBRINOLYTIC-ACTIVITY IN GLOMERULI ISOLATED FROM RABBITS INFUSED WITH TUMOR-NECROSIS-FACTOR. 75
Effect of Ochratoxin A on prothrombotic and proinflammatory activities of stimulated blood mononuclear cells 75
Rebuttal to: Effect of heparin on TAFI-dependent inhibition of fibrinolysis 75
Does inhibiting Sur1 complement rtPA in cerebral ischemia? 74
URINARY PROCOAGULANT AND FIBRINOLYTIC-ACTIVITY IN HUMAN GLOMERULONEPHRITIS - RELATIONSHIP WITH RENAL-FUNCTION 74
Skin extracts from 2 italian table grapes (italia and palieri) inhibit tissue factor expression by human blood mononuclear cells 74
Procoagulant properties of bare and highly-PEGylated vinyl-modified silica nanoparticles 74
The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation. 73
Fibrin down-regulates LPS- and PMA- induced tissue factor expression by blood mononuclear cells 73
Cellular coagulation-fibrinolysis balance and atherosclerosis 70
Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. 70
D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis 69
PLASMINOGEN ACTIVATOR INHIBITOR IN THE BLOOD OF PATIENTS WITH CORONARY-ARTERY DISEASE. 68
Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis 68
Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA 68
A ROLE FOR PLATELETS AND THROMBIN IN THE JUVENILE STROKE OF 2 SIBLINGS WITH DEFECTIVE THROMBIN-ADSORBING CAPACITY OF FIBRIN(OGEN) 67
Thrombin Activatable Fibrinolysis Inhibitor: at the nexus of fibrinolysis and inflammation 67
Increased production of mononuclear cell procoagulant activity in Hodgkin's disease. 67
Expression of tissue factor and vascular endothelial growth factor in colorectal carcinoma 67
Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis 66
The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood 66
Prevention and therapy of experimental venous thrombosis in rabbits by desmin 370 65
EFFECT OF HEPARIN AND OR ANTITHROMBIN-III ON THE GENERATION OF ENDOTOXIN-INDUCED PLASMINOGEN-ACTIVATOR INHIBITOR. 65
HEMOSTATIC VARIABLES IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - EFFECT OF REGULAR PLASMA-CHOLESTEROL REMOVAL BY LOW-DENSITY-LIPOPROTEIN APHERESIS 65
Monoclonal antibodies targeting the antifibrinolytic activity of activated TAFI but not the anti-inflammatory activity on osteopontin and C5a 64
Evidence that cells from experimental tumours can activate coagulation factor X. British journal of cancer. 63
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. 63
TISSUE FACTOR-EXPRESSING MONOCYTES INHIBIT FIBRINOLYSIS THROUGH A TAFI-MEDIATED MECHANISM, AND MAKE CLOTS RESISTANT TO HEPARINS 63
PROPERTIES OF CHIMERIC (TISSUE-TYPE UROKINASE-TYPE) PLASMINOGEN ACTIVATORS OBTAINED BY FUSION AT THE PLASMIN CLEAVAGE SITE 63
NOVEL GLUCOSE-CONJUGATED HIGHLY POTENT DUAL THROMBIN AND FACTOR Xa INHIBITORS AS POTENTIAL ANTITHROMBOTICS 62
Cellular and plasmatic anomalies of the coagulation system and fibrinolysis in children with lymphomas and influence of cytostatic treatment 62
Platelets abolish the profibrinolytic effect of activated protein C 62
Anomalie cellulari e plasmatiche della coagulazione e della fibrinolisi dei linfomi ed effetto della terapia 62
How a β-D-Glucoside Side Chain Enhances Binding Affinity to Thrombin of Inhibitors Bearing 2-Chlorothiophene as P1 Moiety: Crystallography, Fragment Deconstruction Study and Evaluation of Antithrombotic Properties 62
Alterazioni dell'equilibrio coagulativo-fibrinolitico dei monociti e della capacità fibrinolitica plasmatica dei linfomi 61
Estressione del tisuue factor e del vasular endothelial growth factor nel carcinoma del colon retto 60
Totale 8.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.317 0 0 0 0 0 0 292 261 364 113 216 71
2020/20211.468 142 104 124 70 169 95 113 146 169 203 81 52
2021/20221.175 57 200 11 40 60 51 63 53 80 63 200 297
2022/20231.796 264 191 134 163 211 233 23 169 326 13 35 34
2023/2024464 59 102 15 35 29 102 15 21 5 11 18 52
2024/2025680 78 32 213 109 48 182 18 0 0 0 0 0
Totale 11.144